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Objective- Determine the effectiveness of shared decision making to 1) increase 
decisional comfort with the appropriate use of antibiotics for respiratory tract 
infections and 2) maintain antibiotic prescribing rates at current levels. 
Participants- English speaking college students age 18 and over diagnosed with a 
respiratory tract infection in the general medical clinic of a university health 
center from August 31, 2015-May 6, 2016.  
Methods- Pre- and post-intervention surveys used to measure decisional conflict 
of students. Intervention included staff training in shared decision making and the 
use of a decision aid in clinical practice. 
Results- Students who received routine care were 2.2 times more likely to 
experience decisional conflict than students whose care included the decision aid. 
Antibiotic prescribing rates where maintained at pre-intervention levels.   
Conclusions- Use of a decision aid show promise to increase comfort with the 
appropriate treatment of respiratory tract infections while maintaining current 







Introduction and Background 
The World Health Organization (2012) reports that antibiotic resistance is a 
global health emergency which poses a serious threat to modern medicine; making the 
inability to treat common illnesses and injuries no longer a fantasy, but a real possibility. 
Overuse of antimicrobials correlates directly with antibiotic resistance within a 
population (World Health Organization, 2012). Viral respiratory tract infections are a 
major cause of antibiotic use, even though there is no evidence to support their use for 
these infections (Kenealy & Arroll, 2013; World Health Organization, 2012). In 
September 2014 the White House released the National Strategy for Combating 
Antibiotic-resistant Bacteria. Goal one of this strategy calls for the cooperation of 
providers and patients to strengthen antibiotic stewardship.  
Numerous interventions have been studied to decrease the inappropriate use of 
antibiotics for respiratory tract infections; however, no one intervention has been 
identified as best practice (Tonkin-Crine, Yardley, & Little, 2011). The idea of improved 
provider-patient communication and patient centered care, in the form of shared decision 
making, has been gaining attention as a possible intervention (Briel et al. 2006; Elwyn et 
al., 2012; Haltiwanger et al. 2001; Welschen et al., 2004; Zoorob et al., 2001). Shared 
decision making is defined as the interactional exchange of information and deliberation 
between a health care provider and patient (Légaré et al., 2013b). Traditional provider 
patient interactions are passive in that the provider makes the decision without input from 
the patient (Elwyn et al., 2012; Légaré et al., 2013a). Shared decision making is a process 
which encourages patients to move from the traditional passive interaction to a 





patient with the best evidence regarding the risks and benefits of their condition and 
exploring the patient’s values and perceptions (Elwyn et al., 2012; Légaré et al., 2013a). 
Review of Literature 
Evidence based guidelines for the treatment of respiratory tract infections are 
readily available to providers; however, biomedical aspects are not the only factors that 
affect provider’s decisions to prescribe antibiotics. Patient perceptions and expectations 
are often the reason unnecessary antibiotics are prescribed (Altiner et al., 2007; Briel et 
al., 2006).  While education is important, a focus should be placed on provider-patient 
communication to effectively decrease the use of antibiotics for respiratory tract 
infections (Altiner et al., 2007).  
 College health providers are not immune to challenges related to the ethical 
treatment of viral respiratory tract infections and often deal with pressures to prescribe 
unnecessary antibiotics for students. In addition, college health centers are in a unique 
position to educate students regarding the appropriate treatment of respiratory tract 
infections, promoting life-long stewardship of antibiotics (Haltiwanger et al., 2001; 
Zoorob et al, 2001).  The idea of improved provider-patient communication, including 
shared decision making, shows promise for use with college students. Young adults have 
been found to prefer, and even expect, shared decision making when consulting with 
health care providers (Alden, Merz, & Akashi, 2012; Briel et al., 2007). In addition, an 
increase in education level correlates with an increase in preference for shared decision 





 A systematic literature review evaluating the use of shared decision making for 
respiratory tract infections in college students was completed during fall 2014 and serves 
as the background of evidence for this project. The manuscript of this systematic review 
was published in the May-June 2016 issue of the Journal of American College Health 
(Blyer and Hulton, 2015).  
Problem Statement 
The unnecessary use of antibiotics for viral respiratory tract infections contributes 
to antibiotic resistance. Patient perceptions and expectations often lead to the unnecessary 
use of antibiotics. The question to be answered from the implementation of this project is, 
“Does the use of shared decision making within the college health setting increase 
student decisional comfort with the ethical use of antibiotics while maintaining low 
antibiotic prescribing rates for viral respiratory tract infections?”  
Theoretical Model 
The Ottawa Research Institute (2014) five step process for implementation of a 
shared decision making intervention was used as a guide for the implementation process. 
This process is based on the Knowledge to Action Cycle (McDavid, Huse, and Hawthorn, 
2013) and includes the following steps:  
1) Identify the decision;  
2) Find patient decision aids;  
3) Identify barriers and explore ways to over them;  
4.1) Implement decision aids and support;  
4.2) Provide training; and  





See Figure 1 for a depiction of a logic model for this project.  
Project Description 
 The project was conducted as a quality improvement project implementing shared 
decision making into a college health clinic. Implementation included the use of the 
decision aid, “Taking an Antibiotic or Not? Acute Respiratory Tract Infections (ARI)” by 
Labrecque, LeBlance, Légaré, and Cauchon (2010).  Permission to use the aid was 
received in writing from the author.  
Objectives  
Objectives for this project include: 
1) To increase student comfort with the appropriate use of antibiotics for 
respiratory tract infections. 
2) To maintain antibiotic prescribing rates at current rate or lower.  
The vision of the University Health Center’s strategic plan is, “To be the model 
for translating health care and health education into increased student engagement and 
learning.” One objective of this plan is to, “Ensure that our educational programs include 
intentional opportunities for students to learn ethical decision-making skills.”  The 
objectives for this project directly related to the organizations strategic plan by engaging 
students in learning about their health and ethical decision making skills related to the 
appropriate, or ethical, use of antibiotics for respiratory tract infections.  
Pre-intervention prescribing rates for respiratory tract infections in the Health 
Center’s General Clinic are around 33%. According to a Cochrane Review by Coxeter et 





29%. Briel et al. (2006) found that shared decision making did not decrease prescribing 
rates for providers with already low prescribing rates. An initial assessment of 
perceptions related to shared decision making identified provider concerns that shared 
decision making would increase prescribing rates. Considering the fact that the providers 
already have relatively low prescribing rates, shared decision making is not shown to 
decrease low prescribing rates, and the provider’s concerns about increased prescribing, 
objective two, was focused on maintaining prescribing rates at current levels and not 
necessarily on lowering prescribing rates.  
Project Design 
Setting and Resources 
 The project took place in the General Medicine Clinic at the James Madison 
University Student Health Center located in Harrisonburg, Virginia. The University has a 
population in excess of 20,000 students and the health center provides in excess of 30,000 
student visits per year. Respiratory tract infections account for approximately 5000 
student visits per year. Funding for the project was provided through the James Madison 
University Student Affairs Innovation Grant.  
Study Population 
Four providers from the General Medicine Clinic, including two physicians and 
two nurse practitioners, agreed to participate in the study. Project participants included 
English speaking patients 18 years and older who made an appointment with participating 
providers at the University Health Center General Medicine Clinic between August 31, 







  Prior to the start of the study all General Clinic providers were offered 
participation in the study through direct contact. All Health Center staff, including 
providers, where offered access to training whether or not they participated in the study. 
See Appendix A for a copy of the provider consent form.  
The pre-implementation phase of the project took place from August 31, 2015 to 
December 18, 2015. During the pre-implementation phase participating providers offered 
students diagnosed with a respiratory tract infection participation in the study through an 
anonymous survey. Students who choose participation in the study completed the one 
page survey in a waiting area located at check-out and placed it in a locked drop box. 
Please see Appendix B for a copy of the patient cover/consent and survey (survey was 
distributed as a single front and back document). Surveys were color coded per provider.  
 In December, following the pre-implementation phase, participating providers as 
well as all other Health Center staff were offered shared decision making training using 
online training videos developed using the Agency for Healthcare Research and Quality 
(AHRQ) SHARE program. On January 8th, 2016 a hands-on clinical training was also 
offered. The training included an interprofessional role play and discussion of shared 
decision making followed by hands-on practice. The practice sessions included volunteer 
student patients who acted out case studies. This allowed the providers to practice with 





 The post-intervention phase of the project took place from January 11, 2016 to 
May 6, 2016.  During the post-intervention phase providers had the option of using the 
decision aid for patients with symptoms of a respiratory tract infection. Students were 
offered participation in the study using the same survey and method as during the pre-
intervention phase. The use of a decision aid was specified by providers on the bottom of 
the patient survey. See Figure 2 for a visual depiction of the project timeline.  
Sources of Data 
 Antibiotic prescribing rates for respiratory tract infections will be collected during 
both pre-and post- intervention phases using data from the Health Center’s electronic 
health record (EHR) system. EHR reports created for this data included ICD-9/ICD-10 
codes for respiratory tract infections to account for the coding changes that occurred 
during the study. Reports also included the transaction codes for antibiotics commonly 
used for respiratory tract infections.  
 Patient decisional comfort was assessed pre- and post- intervention using the 
SURE test© located on the patient survey (see Appendix A). Permission to use the test 
was obtained in writing from the author. The four items on the SURE test© are summed 
to determine the decisional conflict score for each individual. Scores range from 
extremely high decisional conflict (0) to no decisional conflict (4). A score of ≤ 3 
indicates decisional conflict is present (O’Conner, 1993). A summary of data variables 





 Within one week of study implementation providers reported that the student 
population was making decisions quickly without needing to complete all six steps of the 
decision aid. Providers felt that completing the final steps after students declared their 
decision was redundant and unnecessary. Upon being made aware of this phenomenon 
the researchers received IRB approval to add a Provider Use of Decision Aid Survey to 
the end of the implementation phase (See Appendix C). The purpose of the additional 
survey was to assess the extent of DA use.  
 
Special Note 
 The original project proposal and subsequent IRB addendum included surveys on 
provider intent, use of shared decision making, qualitative feedback, and visit time 
studies. Data collected which relates to providers does not directly relate to the objectives 
for this portion of the study and will not be reported in this executive summary. A 
subsequent data analysis and manuscript based on provider data will be considered at a 
later time.  
Evaluation Plan 
 Data analysis will be completed using SPSS. Decisional conflict directly links to 
objective one and was measured using the SURE test© (see description above). Odds 
ratio was used to determine the effect of each predictor variable on the outcome of 
decisional conflict. Antibiotic prescribing rates directly link to objective two and were 





patients diagnosed with respiratory tract infections. Please see Figure 3 and Table 2 for a 
list of respiratory diagnoses and antibiotics used to determine prescribing rates.  
 
Findings 
The decision aid was the only statistically significant predictor of decisional 
conflict. Those who did not have the decision aid used in consultation were almost 2.2 
times more likely than those who did to experience decisional conflict [N=643; p=<.001; 
95% CI (1.55, 3.12)]. See Table 3 for complete Variables Results. Antibiotic prescribing 
rates did not show any significant difference with antibiotics being prescribed 33.3% of 
the time pre-intervention and 31.7% of the time post-intervention [X2 (1, N=3174)=.922, 
p= .337].  
When using a decision aid all providers reported using steps one and two “almost 
always”. Half of the providers reported using steps three and four “almost always” and 
half reported using steps three and four “sometimes”. Step five was reportedly used from 
“not at all” to “almost always”. Step six of the decision aid was the least used with 
reported use ranging from “not at all” to “sometimes”.  
 The findings answered the question proposed in the project problem statement. 
The use of shared decision making, through the use of a decision aid, increased student 
comfort by over two times that of usual care while maintaining current antibiotic 





objectives by increasing student comfort with appropriate antibiotic prescribing rates 
while maintaining current prescribing rates.   
 The most significant barrier to the study was the varied use of the decision aid. 
The most significant motivation to the use of the shared decision making was steps one 
and two of the decision aid which educated students on the probability that their 
symptoms where bacterial. The providers felt that these steps were the most beneficial 
communication and educational tools for use during the visit. Providers felt that students 
where often quick to make decisions about the use of antibiotics based in this probability. 
No other unintended consequences or findings were identified.  
Recommendations/Implications 
 Haltiwanger, et al. (2001) identified the antibiotic-seeking behaviors of college 
students, reporting that 55% of students being seen for a respiratory tract infections 
expected to receive an antibiotic while only 36% received a prescription for an antibiotic. 
This study identified a clear diagnosis, explanation for treatment, and a prescription for 
an antibiotic as being significantly associated with patient satisfaction. Fifteen years later 
college health centers still struggle with student dissatisfaction when not receiving 
antibiotics for respiratory tract infections and cannot ignore the call to change prescribing 
practices while educating patients about the appropriate use of antibiotics (Blyer and 
Hulton, 2016).  In the current study, the decision aid, “Taking an Antibiotic or Not?” was 
shown to be an effective intervention to improve college student decisional comfort with 
the appropriate use of antibiotics for respiratory tract infections. In addition, the 





antibiotic prescribing rates. College health centers should consider implementation of the 
decision aid to increase students comfort and promote the appropriate use of respiratory 
tract infections.  
This study identifies many implications for further studies. Future studies should 
focus on the effectiveness of the decision aid in varied college health settings including 
those serving large numbers of international students.  In addition, further work should 
also identify which steps of the decision aid are most effective for the college population 
and use this information to adapt the decision aid for the population. Assessment and 
measurement of student learning related to the use of the decision aid would also be 
valuable data and should be considered for future studies. 
 According to Elwyn, G., Frosch, D., and Kobrin, S. (2016) the future of shared 
decision studies lies in a broader conceptualization and measurement of the practice. 
Considering these recommendations along with the findings from this study future 
studies should also focus on long term outcomes of the intervention. For the purpose of 
this study immediate prescribing rates were reported but no other prescribing rates where 
available. Future studies should focus on longer term outcomes such as re-consultation 
rates and prescribing rates within the days and weeks following the initial use of the 
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Consent to Participate in the Project on Shared Decision Making for the 
Ethical Use of Antibiotics 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Kristina B. Blyer, MSN, RN, NE-BC 
from James Madison University.  The purpose of this study is to assess the use of shared decision making 
for the ethical use of antibiotics. This study will contribute to the researcher’s completion of Doctor of 
Nursing Practice (DNP).  
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this consent form once 
all your questions have been answered to your satisfaction.  This study consists of a survey that will be 
administered to individual participants at four points throughout the study.  You will be asked to provide 
answers to a series of questions related to the use of shared decision making for students consulting 
with respiratory tract infections. In addition, participants will be asked to distribute patient surveys 
following consultation for respiratory tract infections.   
Time Required 
Participation in this study will require 10 minutes of your time per survey. Surveys will be given in at four 
points during the study for a total of 30 minutes. Patient surveys will be distributed with visit encounter 
form and should require less than 30 seconds of time for each patient.   
Risks  
The investigator does not perceive more than minimal risks from your involvement in this study (that is, 
no risks beyond the risks associated with everyday life). 
Benefits  
There are no direct benefits for participation in the study. Study finding will contribute to general 
knowledge regarding the use of shared decision making for respiratory tract infections.  
Confidentiality  
The results of this research will be presented to health center staff and administrators, at conferences, 
and in manuscript format. The researcher retains the right to use and publish non-identifiable data.  
While individual responses are obtained and recorded anonymously and kept in the strictest confidence, 
aggregate data will be presented representing averages or generalizations about the responses as a 







whole.  All data will be stored in a secure location accessible only to the researcher. Upon completion of 
the study, all records will be destroyed.  
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you choose to 
participate, you can withdraw at any time without consequences of any kind. 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or after its 
completion or you would like to receive a copy of the final aggregate results of this study, please 
contact: 
Kristina B. Blyer, MSN, RN, NE-BC Dr. Maria DeValpine                                                                        
University Health Center                         Nursing Department 
James Madison University   James Madison University 
blyerkb@jmu.edu                           devalpmg@jmu.edu   
Questions about Your Rights as a Research Subject 
 
Dr. David Cockley                                                                                                                                                             
Chair, Institutional Review Board                                                                                                                                         
James Madison University                                                                                                                                                    
(540) 568-2834                                                                                                                                                 
cocklede@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in this 
study.  I freely consent to participate.  I have been given satisfactory answers to my questions.  The 
investigator provided me with a copy of this form.  I certify that I am at least 18 years of age. 
______________________________________     
Name of Participant (Printed) 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
______________________________________    ______________ 








Cover Letter for Project on Shared Decision Making for the Ethical Use of Antibiotics (Page 1)          
Identification of Investigators & Purpose of Study 
You are being asked to participate in a research study conducted by Kristina B. Blyer, RN, MSN, NE-BC from James 
Madison University.  The purpose of this study is to assess the use of shared decision making for the ethical use of 
antibiotics.  This study will contribute to the researcher’s completion of her doctoral capstone project.                                                                                                                                                                       
Research Procedures 
This study consists of a survey that will be administered to individual participants in the University Health Center 
following a visit for symptoms of a respiratory tract infection.  You will be asked to provide answers to a series of 
questions related to your preferred treatment for respiratory tract infections and your decisional comfort with this 
preferred treatment.                                                                                                                                                                 
Time Required 
Participation in this study will require 2 minutes of your time.                                
Risks 
The investigator does not perceive more than minimal risks from your involvement in this study (that is, no risks 
beyond the risks associated with everyday life).                                                                                                                                                                                      
Benefits 
There are no direct benefits for participation in the study. Study finding will contribute to general knowledge 
regarding the use of shared decision making for respiratory tract infections.                                                                              
Confidentiality                                                                    
The results of this research will be presented to health center staff and administrators, at conferences, and in 
manuscript format. While individual responses are obtained and recorded anonymously and kept in the strictest 
confidence, aggregate data will be presented representing averages or generalizations about the responses as a 
whole.  No identifiable information will be collected from the participant and no identifiable responses will be 
presented in the final form of this study.  All data will be stored in a secure location accessible only to the 
researcher.  The researcher retains the right to use and publish non-identifiable data.  At the end of the study, all 
records will be destroyed.                                                                                                                                                                
Participation & Withdrawal                                                                                                                                                                    
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you choose to 
participate, you can withdraw at any time without consequences of any kind.  However, once your responses have 
been submitted and anonymously recorded you will not be able to withdraw from the study.                                                                                                                      
Questions about the Study                                                                                                                                                 
If you have questions or concerns during the time of your participation in this study, or after its completion or you 
would like to receive a copy of the final aggregate results of this study, please contact:                                                                                            
Kristina B. Blyer, MSN, RN, NE-BC  Dr. Maria DeValpine                                                                          
University Health Center                                 Nursing Department                                                                         
James Madison University   James Madison University                                                      
blyerkb@jmu.edu                   devalpmg@jmu.edu                                        
Questions about Your Rights as a Research Subject                                                                                                   
Dr. David Cockley                                                                                                                                                             
Chair, Institutional Review Board                                                                                                                                     
Appendix B                                                 






James Madison University                                                                                                                                                               
(540) 568-2834                                                                                                                                                 
cocklede@jmu.edu 
Giving of Consent 
I have read this cover letter and I understand what is being requested of me as a participant in this study.  By 
completing this survey I consent to participate.  I have been given satisfactory answers to my questions.  I certify 
that I am at least 18 years of age.                                                                                                                     
__Kristina B. Blyer____________________________________                                                                                                                               
Name of Researcher (Printed)                                   
__________(Signature)_______________    ______________                                                                                                                       







































Treatment Preference and Decisional Comfort Survey (page 2) 
 
Please complete the following questions; all answers are anonymous. 
Which option for the treatment of respiratory tract infections (colds, sinus infections, sore throat, 
bronchitis, or ear infections) do you expect? Please check one. 
a.          Antibiotics 
b.          Non-antibiotic treatment  
c.          Whatever my medical provider recommends based on my symptoms 
d.          Unsure 
 





Do you feel SURE about the best choice for you?   
Do you know the benefits and risks of each option?   
Are you clear about which benefits and risks matter 
most to you? 
  
Do you have enough support and advice to make a 
choice? 
  
                                                                            Adapted from the SURE Test© O’Conner and Légaré, 2008.  
How do you identify? 
        Male             Female            Other  
What is your age? _______ 
What year are you at JMU? 
        Freshman            Sophomore             Junior          Senior          Graduate 
Have you completed this questionnaire (since “August 2015 or January 2016”)? 
              Yes                                No 
 
When completed, please place this form in the secure drop box located at the check-out 
desk.  Thank you for your participation! 
  Provider use only: 
DA 
























Possible Range of 
Values 
Reference Time Frame for collection 
Decisional 
Comfort 











Items are given a score 
value of: 0= no and 1= yes 
 
Items are summed and 
scores rage from 0 
[extremely high decisional 
conflict] to 4 [no decisional 
conflict] 
 
Score of ≤ 3 indicates 
decisional conflict 
Ferron Parayre et al. [1] 
(2014) 
 
O’Conner [3] (1993) 
Pre-intervention 




Jan. 11, 2016- May 6, 2016 







Possible Range of 
Values 













Percentage of antibiotics 












Jan. 11, 2016- May 6, 2016 




























18-99 N/A Pre-intervention 




January 11, 2016- May 6, 2016 
Year in 
College 




























O’Conner [3] (1993) as a 
preliminary question 
for the SURE tool 
Pre-intervention 




January 11, 2016- May 6, 2016 
Use of 
Decision Aid 
Use of decision 











August 31, 2015- December 18, 
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List of Antibiotics  
Condition Comment Medication    
      In House Alchemy 
Otitis Media   Amoxicillin IHAmox875 R10250 
        R18555 
    Amox/clav IHAmxClv14 R21832 
      IHAmoxClav R2172 
  2nd gen ceph cefuroxime   Rcefurox 
        Rcefurox_1 
        Rcefurox_2 
        Rcefurox_3 
        RCeftin2 
        RCeftin5 
    Cefprozil   Rcefproz 
        RCefproz2 
        RCefzil2 
        RCefzil5 
  3rd gen ceph Cefdinir   Rcefdini 
        Rcefdind_2 
        Rcefdini_5 
        Romnicef 
        Romnicef_1 
  formerly Vantin Cefpodoxime   Rcefpodo 
  Less effective Azithromycin IHAzith250 R37088 
        Razithro_1 
        Rzithrom 
        Rzithrom_2 
      "           " Clarithromycin   Rclarith 
        Rclarith_3 
        RBiaxinF 
        RBiaxinF_3 
      "           " SMZ-TMP 
IHSmzTmp 14, 
28, 40   
Pharyngitis Preferred Penicilin V IHPen50030 R3651 
      IHPenV500 Rpenicil 
          







abscess) Amox/clav   As above   
          
  
1st generation 
cephalosporin cephalexin IHCephalex R14486 
        R5773 
        R3521 
  (seldom) Erythromycin   R7288 
        R9637 
        R53475 
        Rerythro_6 
        Rerythro_7 
        Rerythro_8 
  (Abscess)_ Clindamycin IHClind150 Rclindam 
        Rcleocin 
        R49454 
        R47779 
  Less effective Azithromycin as above   
Sinusitis   Amox/clav as above   
    Doxycycline IHDoxy14 R22787 
        R24676 
        R37415 
Bronchitis   Azithromycin as above   
    Amoxicillin as above   
    Amox/clav as above   
  
rarely 2nd, 3rd 
cephalosporin as above as above   
          





Levaquin   Rlevaqui 
        Rlevaqui_1 
        Rlevaqui_2 
    
Moxifloxacin 
Avelox   RAvelox4 








































































ICD 9/10 Diagnosis Codes  
 
Dx Code Description   
J20 Acute Bronchitis 
38100 Acute nonsuppurative otitis media, unspecified 
38101 Acute serous otitis media 
38200 Acute suppurative otitis media without spontaneous rupture of eardrum 
3829 Unspecified otitis media 
r070 Pain in Throat 
460 Acute nasopharyngitis [common cold] 
461 Acute sinusitis 
4610 Acute maxillary sinusitis 
4611 Acute frontal sinusitis 
462 Acute pharyngitis 
463 Acute tonsillitis 
4659 Acute upper respiratory infections of unspecified site 
4660 Acute bronchitis 
J04 Acute laryngitis and tracheitis 
J30.9 Allergic rhinitis, unspecified 
38104 Acute allergic serous otitis media 
38201 Acute suppurative otitis media with spontaneous rupture of eardrum 
38202 Acute suppurative otitis media in diseases classified elsewhere 
477 Allergic rhinitis 
477.2 Allergic rhinitis due to animal (cat) (dog) hair and dander 
477.8 Allergic rhinitis due to other allergen 
477.9 Allergic rhinitis, cause unspecified 
 
 
 
 
 
 
 
